Sign up
Pharma Capital
EPIC: LANCO
Market: PRIVATE-UK
Sector: Pharma & Biotech

The Lancor Blockchain Platform (LBP)

The Lancor Blockchain Platform (LBP) blockchain architecture provides the opportunity for trusted, verifiable, and auditable data, adding a greater level of authenticity to any data generated within its infrastructure.

Our blockchain implementation offers “potential solutions” to many of the issues raised by the WHO. One of the major features of...

Lancor Scientific

www.lancorscientific.com

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Lancor Scientific

Lancor Scientific Snapshot

Our mission :

is to Find Cancer Early.

Our vision :

is that early diagnosis and screening will be available to everyone, everywhere.

 

The ICO Team combines deep knowledge of cancer, government, technology, screening and blockchain with a proven expertise in marketing and commercial delivery.

team
Aamir Butt
CEO
team
Prof. Roland Schlesinger MD
Chief Medical Officer
team
Prof. Paul Darbyshire
CTO
team
Stephen Pigney
CFO
team
Gopal Rao
COO
team
Robert Elding
CMO
team
Prof. Adenike Grange MBChB
Ambassador, Africa Region
team
Ryan Lavelle
Head of Product Delivery
team
Nick Holmes
SVP Engineering and Design
team
Rory Lavelle
Sales Director
team
Victoria Gavaza
Regional Director, Africa
team
Lauren Sterling
Operations Manager
 

SPECIAL ADVISORS

 
team
Dr Khalil Razvi, MB BCh
Special Advisor
team
Professor Dr. A Min Tjoa
Special Advisor
team
Julian Burn-Callander
Compliance Consultant
team
Gary Nuttall
Special Advisor
team
James Barrington-Brown
Special Advisor
team
Siam Kidd
Special Advisor

 

CONTACT

Please get in touch if you have any questions and we’ll get back to you shortly

 

View full LANCO profile View Profile
View All

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.